CCLG Research Talks: Our journey into childhood leukaemia research
Dr Cristina Pina and Dr Sabrina Tosi share how perseverance, new technologies, and collaboration can help children with leukaemia.
James's story
James was diagnosed with medulloblastoma, a type of brain tumour, in 2024 when he was seven years old. His mum, Katie, shares his story.
‘The inspiration behind my childhood leukaemia research’ – with Dr Rhys Morgan
International Childhood Cancer Day happens annually on 15 February. This year, we spoke to Little Princess Trust-funded researcher Dr Rhys Morgan.
New research highlights urgent need for greater awareness to aid early diagnosis of bone cancers in young people
The CCLG-funded Childhood Cancer Smart project has published a paper today calling for greater awareness of the symptoms of bone cancers in children and young adults.
Finding myself after treatment
Lillie Killick was 14 years old when diagnosed with leukaemia in 2010. Now 27, she tells us how some of the support she received after treatment helped to inspire her career choices
Making progress: CCLG’s research journey
First formed to establish clinical trials in childhood cancer, research has always been an integral part of CCLG’s work. Ellie Ellicott, CCLG Research Communications Executive, tells us more about its research journey and how the experiences of those that matter the most are helping shape future directions.
Ask the Expert: Nicky Webb
Nicky Webb, is a clinical nurse specialist for the long-term follow-up of survivors of childhood cancer at the East Midlands Children and Young Person's Integrated Cancer Service. She is also a CCLG member and plays an active role in CCLG's specialist Late Effects Group.
A parent’s view... How support helped with moving forward during and after treatment
Sarah Davis' daughter Emma was diagnosed with acute lymphoblastic leukaemia (ALL) as a 12-year-old. She writes about the support the family received and the progress Emma has made since finishing treatment
Innovations in treatment delivery
It’s not just the type of treatments that doctors look to improve, but the way they can be delivered so they are safer and more effective, too. We hear from two leading experts on already established advancements in eye cancer treatment, and a developing example of progress in brain tumour therapy.